These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 10069671

  • 1. In vivo pharmacologic profile of SK-1080, an orally active nonpeptide AT1-receptor antagonist.
    Lee BH, Seo HW, Kwon KJ, Yoo SE, Shin HS.
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):375-82. PubMed ID: 10069671
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological characterization of KR-30988, a novel non-peptide AT1 receptor antagonist, in rat, rabbit and dog.
    Lee BH, Lee SH, Jung YS, Seo HW, Yoo SE, Shin HS.
    J Pharm Pharmacol; 1999 Oct; 51(10):1191-200. PubMed ID: 10579691
    [Abstract] [Full Text] [Related]

  • 3. Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT1-receptor antagonist.
    Lee SH, Jung YS, Lee BH, Yun SI, Yoo SE, Shin HS.
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):367-74. PubMed ID: 10069670
    [Abstract] [Full Text] [Related]

  • 4. Effects of the new angiotensin II type 1 receptor antagonist KRH-594 on several types of experimental hypertension.
    Inada Y, Murakami M, Kaido K, Nakao K.
    Arzneimittelforschung; 1999 Jan; 49(1):13-21. PubMed ID: 10028373
    [Abstract] [Full Text] [Related]

  • 5. Pharmacologic profile of TA-606, a novel angiotensin II-receptor antagonist in the rat.
    Hashimoto Y, Ohashi R, Kurosawa Y, Minami K, Kaji H, Hayashida K, Narita H, Murata S.
    J Cardiovasc Pharmacol; 1998 Apr; 31(4):568-75. PubMed ID: 9554806
    [Abstract] [Full Text] [Related]

  • 6. In vivo pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonist.
    Cazes M, Provost D, Versigny A, Cloarec A.
    Eur J Pharmacol; 1995 Sep 15; 284(1-2):157-70. PubMed ID: 8549620
    [Abstract] [Full Text] [Related]

  • 7. Comparative cardiovascular effects of the angiotensin II type 1 receptor antagonists ZD 7155 and losartan in the rat.
    Junggren IL, Zhao X, Sun X, Hedner T.
    J Pharm Pharmacol; 1996 Aug 15; 48(8):829-33. PubMed ID: 8887734
    [Abstract] [Full Text] [Related]

  • 8. Cardiovascular effects of GR117289, a novel angiotensin AT1 receptor antagonist.
    Hilditch A, Hunt AA, Gardner CJ, Twissell DJ, Polley J, Travers A, Drew GM, Middlemiss D, Ross BC, Robertson MJ.
    Br J Pharmacol; 1994 Jan 15; 111(1):137-44. PubMed ID: 8012689
    [Abstract] [Full Text] [Related]

  • 9. Comparative study of TA-606, a novel angiotensin II receptor antagonist, with losartan in terms of species difference and orthostatic hypotension.
    Hashimoto Y, Ohashi R, Minami K, Narita H.
    Jpn J Pharmacol; 1999 Sep 15; 81(1):63-72. PubMed ID: 10580372
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist.
    Shibasaki M, Fujimori A, Takanashi M, Kusayama T, Tokioka T, Satoh Y, Okazaki T, Uchida W, Inagaki O, Yanagisawa I.
    Eur J Pharmacol; 1997 Sep 24; 335(2-3):167-73. PubMed ID: 9369370
    [Abstract] [Full Text] [Related]

  • 11. Antihypertensive activity of a nonpeptide angiotensin II receptor antagonist, YM358, in rats and dogs.
    Shibasaki M, Fujimori A, Kusayama T, Tokioka T, Satoh Y, Okazaki T, Uchida W, Inagaki O, Yanagisawa I.
    Eur J Pharmacol; 1997 Sep 24; 335(2-3):175-84. PubMed ID: 9369371
    [Abstract] [Full Text] [Related]

  • 12. Effects of U-97018 on pressor responses to intracerebroventricularly administered angiotensin II in conscious normotensive rats.
    Morita O, Kushida H, Kunihara M.
    J Cardiovasc Pharmacol; 1995 Jun 24; 25(6):880-7. PubMed ID: 7564332
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models.
    Lacour C, Canals F, Galindo G, Cazaubon C, Segondy D, Nisato D.
    Eur J Pharmacol; 1994 Nov 03; 264(3):307-16. PubMed ID: 7698170
    [Abstract] [Full Text] [Related]

  • 14. Pharmacologic profiles of KRH-594, a novel nonpeptide angiotensin II-receptor antagonist.
    Tamura K, Okuhira M, Amano H, Inokuma K, Hirata T, Mikoshiba I, Hashimoto K.
    J Cardiovasc Pharmacol; 1997 Nov 03; 30(5):607-15. PubMed ID: 9388043
    [Abstract] [Full Text] [Related]

  • 15. Pharmacology of XR510, a potent orally active nonpeptide angiotensin II AT1 receptor antagonist with high affinity for the AT2 receptor subtype.
    Wong PC, Quan ML, Saye JM, Bernard R, Crain EJ, McCall DE, Watson CA, Zaspel AM, Smith RD, Wexler RR.
    J Cardiovasc Pharmacol; 1995 Sep 03; 26(3):354-62. PubMed ID: 8583775
    [Abstract] [Full Text] [Related]

  • 16. In vivo pharmacology of DuP 753.
    Wong PC, Price WA, Chiu AT, Duncia JV, Carini DJ, Wexler RR, Johnson AL, Timmermans PB.
    Am J Hypertens; 1991 Apr 03; 4(4 Pt 2):288S-298S. PubMed ID: 1854454
    [Abstract] [Full Text] [Related]

  • 17. Pharmacology of LR-B/081, a new highly potent, selective and orally active, nonpeptide angiotensin II AT1 receptor antagonist.
    Cirillo R, Renzetti AR, Cucchi P, Guelfi M, Salimbeni A, Caliari S, Castellucci A, Evangelista S, Subissi A, Giachetti A.
    Br J Pharmacol; 1995 Mar 03; 114(6):1117-24. PubMed ID: 7620700
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.
    Criscione L, de Gasparo M, Bühlmayer P, Whitebread S, Ramjoué HP, Wood J.
    Br J Pharmacol; 1993 Oct 03; 110(2):761-71. PubMed ID: 8242249
    [Abstract] [Full Text] [Related]

  • 19. Effects of systemic treatment with irbesartan and losartan on central responses to angiotensin II in conscious, normotensive rats.
    Culman J, von Heyer C, Piepenburg B, Rascher W, Unger T.
    Eur J Pharmacol; 1999 Feb 19; 367(2-3):255-65. PubMed ID: 10079000
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological Profiles of a Highly Potent and Long-Acting Angiotensin II Receptor Antagonist, Fimasartan, in Rats and Dogs after Oral Administration.
    Paik SH, Chi YH, Lee JH, Han HS, Lee KT.
    Biol Pharm Bull; 2017 Feb 19; 40(7):992-1001. PubMed ID: 28674263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.